net income jumped in its fiscal first quarter, boosted by its drug-distribution business.
The supplier of drugs and other products for the healthcare industry said its net profit rose to $288.3 million, or 64 cents a share, compared with $176.3 million, or 38 cents a share, a year earlier.
The results include charges of $15.6 million, or 3 cents a share, mainly due to merger-related costs. Excluding items in both quarters, the company posted earnings of 67 cents a share, compared with 55 cents a share a year earlier.
Revenue rose 16% to $11.42 billion from $9.87 billion a year earlier.